UBS Maintains a 'Neutral' on Kemet (KEM); Strong 4Q11 But Visibility Remains Limited
Tweet
Share
E-mailGet Alerts KEM Hot Sheet
Price: $27.58 --0%
Rating Summary:
3 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Kemet (NYSE: KEM), raises PT from $16 to $17.
UBS analyst says, "KEM had a strong finish to FY11 with Revs/EPS of $262m/$0.49 coming in ahead of consensus at $248m/$0.40 and UBSe $248m/$0.38. Revs declined 1% Q/Q vs. guidance of down 5-8%, primarily on strength in the core capacitor business...We believe there was likely some modest benefit from orders late in the Qtr relating to the Japan crisis."
"We adjust our model and now foresee FY12/FY13 Revs/EPS of $1.05b/$1.90 and $1.09/$2.13 vs. $1.02b/$1.98 and $1.076b/$2.13 prev. We est GM of 25.2%/26.8% vs. 26.7%/27.4% prev. as we foresee modest GM improvement rest of FY12."
For more ratings news on Kemet click here and for the rating history of Kemet click here.
Shares of Kemet closed at $16.45 yesterday.
UBS analyst says, "KEM had a strong finish to FY11 with Revs/EPS of $262m/$0.49 coming in ahead of consensus at $248m/$0.40 and UBSe $248m/$0.38. Revs declined 1% Q/Q vs. guidance of down 5-8%, primarily on strength in the core capacitor business...We believe there was likely some modest benefit from orders late in the Qtr relating to the Japan crisis."
"We adjust our model and now foresee FY12/FY13 Revs/EPS of $1.05b/$1.90 and $1.09/$2.13 vs. $1.02b/$1.98 and $1.076b/$2.13 prev. We est GM of 25.2%/26.8% vs. 26.7%/27.4% prev. as we foresee modest GM improvement rest of FY12."
For more ratings news on Kemet click here and for the rating history of Kemet click here.
Shares of Kemet closed at $16.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
